| 000 | 01614 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514011858.0 | ||
| 264 | 0 | _c20011204 | |
| 008 | 200112s 0 0 eng d | ||
| 022 | _a1525-4135 | ||
| 024 | 7 |
_a10.1097/00042560-200110010-00016 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHossain, M M | |
| 245 | 0 | 0 |
_aInhibition of HIV replication by A77 1726, the active metabolite of leflunomide, in combination with pyrimidine nucleoside reverse transcriptase inhibitors. _h[electronic resource] |
| 260 |
_bJournal of acquired immune deficiency syndromes (1999) _cOct 2001 |
||
| 300 |
_a199-201 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAniline Compounds _xblood |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xpharmacology |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
| 650 | 0 | 4 | _aCrotonates |
| 650 | 0 | 4 |
_aHIV _xdrug effects |
| 650 | 0 | 4 |
_aHIV Core Protein p24 _xbiosynthesis |
| 650 | 0 | 4 | _aHIV Seronegativity |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxybutyrates _xblood |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xpharmacology |
| 650 | 0 | 4 |
_aIsoxazoles _xblood |
| 650 | 0 | 4 | _aLeflunomide |
| 650 | 0 | 4 |
_aLymphocytes _xdrug effects |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xblood |
| 650 | 0 | 4 | _aToluidines |
| 650 | 0 | 4 |
_aVirus Replication _xdrug effects |
| 650 | 0 | 4 |
_aZidovudine _xpharmacology |
| 700 | 1 | _aMargolis, D M | |
| 773 | 0 |
_tJournal of acquired immune deficiency syndromes (1999) _gvol. 28 _gno. 2 _gp. 199-201 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00042560-200110010-00016 _zAvailable from publisher's website |
| 999 |
_c11508823 _d11508823 |
||